Wisconsin’s GOP Assembly The Legitius pointed out to legislators in the state “I can find agreement to legalize medical marijuana. But he added that The new Cannabis Bill presented Billpart of his Leadership in the Senate It is “unlikely” to exceed his chamber “is a broad and extensive way.”
“I’ve tried for five or six years” Loudspeakers Robin Vos (R) I said speaker on a conversation with Wisn-Tv on Sunday. “The idea that we will have medicine dispensers in all cities around the state, I don’t know where most people are.”
“So we tried to be a much more limited version,” Let’s look at five or six discharge Americans (and) to help people who are not actually sick of diagnosis, “he said in the new interview.
But the model of the state had a controversial among his Republican colleagues, and suddenly stopped. Now, Vos last week’s President Mary Felzkowski (R) and GOP Legislature will be emerging concerns about new legislation included in other traditional protection systems.
“I still think it’s like trying to find agreement, but it’s like a version that was released, people worrying that people will bring leisure marijuana.” “I don’t want that.”
The speaker said it was “unlikely” that the Senate bills could be cleaned enough to clean the assembly.
“There is a whole group of Republic I understand, because they think it will be out of the recreation marijuana, that it would be horrible for Wisconsin,” he said. “There is another group that wants to legalize marijuana, and they are democrats, so they don’t want to be a real restriction.”
“So it’s very difficult to try to find the central consensus, and that’s why I thought it was a very scale, aimed at people who were really sick and poor. However, it will not be seen in a scenario.”
Asked the new bill of Senate boss, vos celurbill “Probably” should not be reached.
Last week, Felzkowski (R), previously supported another project in Cannabis Bill. Patrick testin (r) Sen. R) presented a new measure.
The text of the proposal was not immediately available, but Felzkowski would have previously invoices Doctors allow patients to issue medical cannabis recommendations One of eight conditions, including cancer, seizure disorders, traumatic stress cover and multiple sclerosis.
Legislation was relatively restrictive because the prohibited marijuana products were banned and did not raise their patients for personal authorization. Patients could only get cannabis preparations for oil, tablets, inkjet or topical.
“Someone who suffers a serious health condition should not be chance to travel to another state or break the law, try alternative medicine for relief,” said Felzkowski in a press release.
“This legislation is about providing a chronic disease to our friends, family members and neighbors, the freedom to study another chance with the doctor,” he said. “It is also possible for our small business businesses to participate in this market with reasonable regulations for making and selling products, all protecting public security.”
The survey found the support for cannabis reform, usually since the organization has first started, since the continued public opinion of legalization in 2013, 67% of the voters protect the policy change. That’s 17% higher than the results of 2013.
Democrats are the best legalizing cannabis, in 88 percent, and then independent (79 percent). However, most Republicans (56 percent) said they are against the legalization of adults.
“I don’t think anyone marijuana and thc products are not believed that marijuana and thc products are not available when they are available in line lines, so I think we need to get to an answer about this,” the leader of the General Assembly. Tyler said August (r) in February. “I hope we can.”
“We will call the marijuana doctor if we have to be treated as pharmacy. But the marijuana discussion will be something that will leave,” Dan Feyen (R), the Majority Assistant said at the time. “Margins are more closely.”
Provided his intention as long as he previews January into Marijuana LegalizationWhile the residents of the State must propose new laws, putting binding questions about linking chanabis reform, being able to enjoy the support of Bipartis, has repeatedly refused the GOP-controlled legislature.
Before, in 2022, the governor signed a corrective order with a specific goal of calling a special legislature give people right to dispose of citizen initiativesElectrations of cannabis to decide to collect expectations among the advocates that the voters could decide. The GOP legislature did not take the proposal, however.
“We worked hard in the last five years, several budgets, to happen,” he said at the time. “I know we are surrounded by states of recreation marijuana, and we will continue to do that.”
New York State’s Office of Cannabis Management (OCM) has recalled several cannabis products after finding that reported results from a testing laboratory were “unreliable.”
OCM says it has found a total of 54 product lots that tested false positive for Aspergillus, the mold that causes disease. According to OCM, another batch of product had incorrect results for the heavy metal cadmium.
“When test results are inaccurate or unclear, product safety and, in turn, the safety of New York State consumers cannot be guaranteed,” said OCM Executive Deputy Director of Licensing, Enforcement and Laboratories Stephen Geskey. “It’s not a risk OCM is willing to take.”
This information comes from an audit of inspections and records conducted by Keystone State Testing New York between December 2025 and January 2026. According to OCM, there have been no reports of the effects of consuming any of the products.
The march to legalize the sale of recreational marijuana in Virginia continues, with the full House of Representatives and a Senate committee advancing a pair of bills to create a regulated adult cannabis market in the commonwealth.
The House on Tuesday approved the second reading of the cannabis sale bill passed by the Senate, giving it the chance to pass it definitively in the chamber. Earlier, a House measure moved through the Senate Finance and Appropriations Committee on a 10-5 vote, sending the measure back to the floor for consideration.
Both chambers’ marijuana-sale proposals aim to give adults a legal way to buy cannabis, legalizing both state possession and home cultivation in 2021, though there are key differences between them.
Bicameral measures—HB 642 and SB 542—Recently changed to allow micro business licensees to cultivate, process or conduct retail sales at two locations instead of one, as long as they are within 10 miles of each other and operate under common ownership and control.
Lawmakers also revised the legislation to clarify that current medical cannabis businesses would only be able to grow cannabis indoors, including in secure greenhouses with a total hood of 70,000 square feet. The amendments also would not allow additional marijuana licenses with “dual-use privileges” beyond medical licenses.
Finally, the measure’s conversion fee structure was revised to pay current medical marijuana companies the privilege of dividing the adult-use market into three parts.
There are some key differences between the House bills that still need to be ironed out — related to the start date of legal sales and cannabis tax rates — before a final product can be delivered to the governor’s desk.
Here are the key details of Virginia’s marijuana sales legalization legislation, SB 542 and HB 642:
Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products, as determined by regulators.
The House bill sets a statewide sales date of Nov. 1, 2026, while the Senate measure would allow it to begin on Jan. 1, 2027.
The Senate bill would impose a 12.875 percent excise tax on cannabis products, in addition to a 1.125 percent state sales tax and a mandatory 3 percent local tax. The House measure would apply a 6 percent excise tax, as well as a 5.3 percent retail sales and use tax, allowing municipalities to impose a 3.5 percent local tax.
Under the House bill, the Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry, while the Senate legislation calls for a new combined Alcoholic Beverage and Cannabis Control Authority.
The House bill calls for the proceeds to be allocated to a new Cannabis Equity Reinvestment Fund (60 percent), early childhood education (10 percent), the Department of Behavioral and Developmental Health Services (25 percent) and public health initiatives (5 percent). The Senate proposal, on the other hand, would put 30 percent into the capital reinvestment fund, 40 percent for early childhood education, 25 percent for the department of behavioral and developmental health services and 5 percent for public health initiatives.
Local governments could not allow marijuana companies to operate in their area.
Delivery services would be allowed.
Serving sizes would be limited to 10 milligrams of THC, with no more than 100 mg of THC per package.
Existing medical cannabis operators could enter the adult-use market if they pay a license conversion fee set at $15 million in the Senate bill and $10 million in the House measure.
Cannabis businesses should implement peaceful labor agreements with their employees.
A legislative committee would direct the addition of local consumer licenses and micro-enterprise cannabis event permits that would allow licensees to hold sales at farmers markets or pop-up locations. The Virginia Alcoholic Beverage Control Authority would also investigate the possibility of involvement in marijuana regulation and enforcement.
As for the Senate marijuana sales bill, members recently clashed in committee over amendments to the body version that would add new penalties for illegal cannabis activity.
The amendments in the Judiciary Committee’s case included penalties for consumers who purchase from unlicensed sources, recriminalizing possession and sale of cannabis by those under 21, making it a Class 1 felony for a first offense and a felony punishable by a mandatory prison sentence for a second offense. As revised, the bill would also increase the penalty for unlicensed cultivation to a felony with up to five years in prison and make it a felony to transport cannabis with the intent to distribute it across state lines.
But the Finance and Appropriations Committee backed down the amendments last month, sending a letter to senators under pressure from a coalition of advocacy groups. saying that they undermined the “intent” of the legislation and “the will of the people” by adding criminal penalties to certain cannabis-related activities.
Members of the Senate and House Judiciary Committees approved alternate versions of the opposite chamber’s reform bill on Monday, setting the stage for bicameral negotiations as the measures move through the legislative process.
Legislation introduced in both chambers would create a process to consider changing the sentences under which people incarcerated or on community custody for certain felonies involving the possession, manufacture, sale or distribution of marijuana could receive an automatic trial.
Del. According to the proposal by Nadarius Clark (D), a parent or guardian’s own use of cannabis “shall not serve as a basis for a finding of abuse or neglect of a child unless other facts establish that its possession or consumption causes or produces physical or mental injury to the child.”
“A person’s legal possession or consumption of substances permitted (under state marijuana law) shall not serve as a basis for limiting custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” reads the text of HB 942.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
Evidena Care AG is one of the leading Swiss telemedicine platforms and specialized medical practices for medical cannabis. The company currently supports more than 2,000 patients across the country. Under the direction of Dr. Nicolai Berardi and two other specialist doctors, Evidena Care has focused on evidence-based, responsible and patient-centered treatment for the past two years.
Now, Evidena Care is launching a nationwide online comparison portal for medical cannabis products. The platform is designed for patients who already have a valid medical prescription and want a clear and reliable view of the market. For the first time in Switzerland, patients can directly compare products and prices from the country’s largest pharmacies in one place.
Medical cannabis plays an essential role in the treatment plans of many patients. At the same time, prices can vary significantly between pharmacies, even when the products contain the same levels of active ingredients. As these costs are often not covered by health insurance, or only partially covered, many patients have a heavy financial burden. The new portal addresses this issue by bringing transparency to a market that until now has been difficult to navigate.
The platform provides an overview of available products and dosages, clearly lists the active ingredient content, such as THC and CBD levels, and displays the current prices of leading Swiss pharmacies. Patients can directly compare options and make informed decisions that help optimize their therapy costs, without compromising medical guidance.
“Patients should not be victims of non-transparent pricing structures,” says Dr. Nicolai Berardi, CEO of Evidena Care AG. “We are creating transparency with our comparison portal, strengthening the self-responsibility of those affected and promoting fair competition in the interests of patients.”
The portal is only for people with a valid prescription. It serves as a true information tool and supports cost optimization in an existing therapy supervised by a physician.